Publication | Closed Access

Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers

Tobacco CessationTobacco ControlMolecular PharmacologyTobacco UseNicotinePharmacology40-Week Follow-upDose-response StudyPharmacotherapyPharmacologic InterventionPublic HealthMedicineJapanese Smokers